PMID: 16086592

Bhatia A, Schafer HJ, Hrycyna CA
Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers.
Biochemistry. 2005 Aug 16;44(32):10893-904., 2005-08-16 [PubMed]
Sentences
No. Mutations Sentence Comment
4 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:4:96
status: VERIFIED
view ABCG2 p.Asp210Asn details
Expression of an ABCG2 variant mutated in a conserved residue in the Walker B motif of the NBD (D210N) resulted in a non-functional protein expressed at the cell surface. Login to comment
5 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:5:53
status: VERIFIED
view ABCG2 p.Asp210Asn details
Expression of an ABCG2 chimeric dimer containing the D210N mutation in the first ABCG2 resulted in a dominant-negative phenotype, as the protein was expressed at the surface but was not functional. Login to comment
47 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:47:92
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:47:133
status: VERIFIED
view ABCG2 p.Arg482Gly details
All experiments detailed in this paper make use of these gain-of-function mutations, either R482T in the MCF-7/AdVp3000 cell line or R482G in the transiently transfected HeLa cells. Login to comment
49 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:49:102
status: VERIFIED
view ABCG2 p.Arg482Gly details
HeLa cells (cervical epitheliod carcinoma) were cultured in DMEM complete media at 37 °C. ABCG2 (R482G) was overexpressed by transient transfection using the T7 vaccinia virus system as described previously (43). Login to comment
50 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:50:33
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 monomers, chimeric dimers, D210N variants, and extracellular cysteine-less variants were cloned into the pTM1 vector where expression was under the control of the T7 promoter. Login to comment
52 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:52:152
status: VERIFIED
view ABCG2 p.Arg482Thr details
MCF-7 cells (breast adenocarcinoma) selected and maintained in 3 µg/ mL doxorubicin and 5 µg/mL verapamil (MCF-7/AdVp3000) overexpress ABCG2 (R482T) at the plasma membrane. Login to comment
57 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:57:75
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:57:76
status: NEW
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:57:90
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:57:91
status: NEW
view ABCG2 p.Asp210Asn details
Cloning and Expression of ABCG2-ABCG2, ABCG2-MABCG2, ABCG2-P-ABCG2, ABCG2 (D210N), ABCG2 (D210N)-ABCG2, and ABCG2∆EC-C. Login to comment
59 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:59:41
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2-ABCG2 encodes two identical ABCG2 (R482G) proteins connected by a SacII restriction enzyme site which adds a proline-arginine linker (PR). Login to comment
60 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:60:33
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2-M-ABCG2 encodes two ABCG2 (R482G) proteins linked by the sequence (PR-NEVELENAADE- SKSEIDALEMSSNDSRSSLIRKRSTRRSVRGSQAQDR- KLSTKEALD-PR) derived from the flexible linker region of human P-glycoprotein. Login to comment
61 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:61:33
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2-P-ABCG2 encodes two ABCG2 (R482G) proteins linked by the sequence (PR- KRMKKRGVLTEKNANDPENVGERSDLSSDRKMLQ- ESSEEESDTYGEIGLSKSEAIFHWRNLCYEVQIKAE- PR) derived from the flexible linker region of yeast ABC transporter PDR5. Login to comment
64 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:64:110
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:64:7
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 (D210N) was constructed by site-directed mutagenesis of aspartate 210 of the parent plasmid pTM1-ABCG2 (R482G). Login to comment
65 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:65:7
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:65:60
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:65:91
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 (D210N)-ABCG2 was built using a combination of ABCG2 (D210N) and ABCG2-ABCG2; ABCG2 (D210N) was altered to include a SacII site immediately upstream of the XhoI site. Login to comment
66 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:66:153
status: VERIFIED
view ABCG2 p.Asp210Asn details
The stop codon was then deleted, and the SacII to XhoI fragment from ABCG2-ABCG2 (the second gene of the chimeric dimer) was inserted in the pTM1-ABCG2 (D210N) vector. Login to comment
67 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:67:203
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Cys592Ala
X
ABCG2 p.Cys592Ala 16086592:67:102
status: VERIFIED
view ABCG2 p.Cys592Ala details
ABCG2 p.Cys603Ala
X
ABCG2 p.Cys603Ala 16086592:67:109
status: VERIFIED
view ABCG2 p.Cys603Ala details
ABCG2 p.Cys608Ala
X
ABCG2 p.Cys608Ala 16086592:67:116
status: VERIFIED
view ABCG2 p.Cys608Ala details
ABCG2∆EC-C, which contains all three endogenous extracellular cysteines replaced with alanine (C592A, C603A, C608A), was constructed by site-directed mutagenesis of the parent plasmid pTM1-ABCG2 (R482G). Login to comment
109 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:109:15
status: VERIFIED
view ABCG2 p.Arg482Gly details
RESULTS ABCG2 (R482G) Chimeric Dimers Are Expressed at the Cell Surface and Transport ABCG2 Substrates. Login to comment
111 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:111:101
status: VERIFIED
view ABCG2 p.Arg482Gly details
In all of the experiments presented here involving transient expression of ABCG2, we used the ABCG2 (R482G) variant because it has a broader substrate specificity than the wild-type protein (39-41, 46). Login to comment
112 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:112:48
status: VERIFIED
view ABCG2 p.Arg482Gly details
Throughout, the designation ABCG2 refers to the R482G variant unless otherwise noted. Login to comment
133 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:133:120
status: VERIFIED
view ABCG2 p.Arg482Gly details
HeLa cells were co-infected/transfected with plasmid DNA constructs of the empty vector pTM1 (gray shaded peak), ABCG2 (R482G) (black thick line), ABCG2-ABCG2 (gray thick line), ABCG2-M-ABCG2 (black thin line), or ABCG2-P-ABCG2 (dashed line). Login to comment
136 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:136:129
status: VERIFIED
view ABCG2 p.Arg482Gly details
HeLa cells were co-infected/transfected in six-well plates with plasmid DNA constructs of the empty vector pTM1 (lane 1), ABCG2 (R482G) (lane 2), ABCG2-ABCG2 (lane 3), ABCG2-M-ABCG2 (lane 4), and ABCG2-P-ABCG2 (lane 5). Login to comment
153 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:153:89
status: VERIFIED
view ABCG2 p.Arg482Gly details
After 24 h at 32 °C, cells were harvested and incubated with the fluorescent ABCG2 (R482G) substrates rhodamine 123 or mitoxantrone for 30 min at 37 °C, followed by a second incubation for 30 min in drug-free media to allow for transporter-mediated efflux. Cellular drug accumulation was analyzed using flow cytometry. Login to comment
159 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:159:50
status: VERIFIED
view ABCG2 p.Arg482Gly details
A Single Mutation in the Walker B Motif of ABCG2 (R482G) Monomers and Chimeric Dimers Abrogates Function but Not Cell Surface Expression. Login to comment
160 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:160:128
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:160:158
status: VERIFIED
view ABCG2 p.Asp210Asn details
To examine the effects of mutations to the ATP binding site on ABCG2 function, we constructed a variant of the monomeric ABCG2 (R482G) in the Walker B motif (D210N), thought to be involved in magnesium binding. Login to comment
162 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:162:47
status: VERIFIED
view ABCG2 p.Asp210Asn details
We evaluated cell surface expression of ABCG2 (D210N) by flow cytometry using the monoclonal antibody 5D3 that recognizes an external epitope of ABCG2 (18), followed by incubation with a FITC-conjugated secondary antibody for detection (Figure 2A), as well as by cell surface biotinylation experiments (Figure 2B). Login to comment
163 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:163:23
status: VERIFIED
view ABCG2 p.Asp210Asn details
This construct, ABCG2 (D210N), is expressed at the cell surface by both of these assays but is not functional for either rhodamine 123 or mitoxantrone transport (Figure 2C,D). Login to comment
164 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:164:106
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:164:11
status: VERIFIED
view ABCG2 p.Asp210Asn details
The ABCG2 (D210N) monomer is recognized better by the conformation-sensitive 5D3 antibody than the ABCG2 (R482G) protein, as demonstrated by the greater shift in fluorescence intensity, suggesting that the presence of the mutation may have caused a conformational change in the protein (47). Login to comment
165 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:165:90
status: VERIFIED
view ABCG2 p.Asp210Asn details
We then incorporated this variant into the first gene of the chimeric ABCG2 dimer [ABCG2 (D210N)- ABCG2] and assessed cell surface expression and function by the assays described above. Login to comment
166 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:166:26
status: VERIFIED
view ABCG2 p.Asp210Asn details
We determined that ABCG2 (D210N)-ABCG2 is expressed at the cell surface by both flow cytometry analysis with the 5D3 antibody (Figure 2A) and cell surface biotinylation (Figure 2B). Login to comment
167 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:167:162
status: VERIFIED
view ABCG2 p.Asp210Asn details
However, the transport function of this chimera is completely abrogated (Figure 2C,D), showing a pattern similar to both the pTM1 negative control and the ABCG2 (D210N) monomer. These data indicate that two intact ATP sites are necessary for function, as has been established for numerous full-length ABC transporters, and suggest that ABCG2 functions as a dimer. Login to comment
168 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:168:55
status: VERIFIED
view ABCG2 p.Asp210Asn details
We did not construct the ABCG2 chimeric dimer with the D210N mutation introduced into the second ABCG2 gene, but we predict a similar dominant-negative effect if the protein proved to fold properly. Login to comment
173 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:173:217
status: VERIFIED
view ABCG2 p.Arg482Thr details
Because the cross-linker is not cell permeable, these experiments were performed in crude membrane preparations of drug-selected MCF-7/AdVp3000 cells that overexpress a homogeneously glycosylated population of ABCG2 (R482T) (Figure 3A, lane 1). Login to comment
174 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:174:133
status: VERIFIED
view ABCG2 p.Arg482Thr details
Membrane preparations from these cells were used because of their uniform banding pattern on SDS-PAGE and their high level of ABCG2 (R482T) expression. Login to comment
175 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:175:43
status: VERIFIED
view ABCG2 p.Arg482Thr details
In the absence of the cross-linker, ABCG2 (R482T) migrates as a monomer by SDS-PAGE analysis (Figure 3A, lane 1). Login to comment
184 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:184:302
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:184:343
status: VERIFIED
view ABCG2 p.Asp210Asn details
Therefore, we used the non-membrane-permeable bifunctional sulfhydryl-reactive cross-linker DPDPB [1,4-di[3'-(2'-pyridyldithio)propionamido]butane] that has a spacer length of 19.9 Å (49) to determine if these extracellular FIGURE 2: Cell surface expression and drug efflux activity of the ABCG2 (D210N) monomer and chimeric dimer ABCG2 (D210N)- ABCG2. Login to comment
186 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:186:120
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:186:185
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:186:221
status: VERIFIED
view ABCG2 p.Asp210Asn details
HeLa cells were co-infected/transfected with plasmid DNA constructs of the empty vector pTM1 (gray shaded peak), ABCG2 (R482G) (black thick line), ABCG2-ABCG2 (gray thick line), ABCG2 (D210N) (black thin line), or ABCG2 (D210N)-ABCG2 (dashed line). Login to comment
189 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:189:105
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:189:129
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:189:179
status: VERIFIED
view ABCG2 p.Asp210Asn details
HeLa cells were co-infected/transfected in six-well plates with plasmid DNA constructs containing ABCG2 (R482G) (lane 1), ABCG2 (D210N) (lane 2), ABCG2-ABCG2 (lane 3), and ABCG2 (D210N)-ABCG2 (lane 4). Login to comment
191 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:191:506
status: VERIFIED
view ABCG2 p.Asp210Asn details
Cells were washed with buffer containing 100 mM glycine to bind excess biotin prior to cell lysis. Biotinylated proteins were solubilized in RIPA buffer and then selected with monomeric avidin beads. Cell surface proteins were denatured with 1× Laemmli sample buffer containing -ME, separated by SDS-PAGE (7.5% gel), and detected by immunoblot analysis using the monoclonal antibody BXP-21 (1:1000) as described in Experimental Procedures. (C, D) Drug accumulation in HeLa cells expressing the ABCG2 (D210N) monomer and chimeric dimer. Login to comment
193 ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:193:350
status: VERIFIED
view ABCG2 p.Asp210Asn details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:193:387
status: VERIFIED
view ABCG2 p.Asp210Asn details
Cells were harvested by centrifugation and incubated with drug-free media for an additional 30 min at 37 °C to allow for drug efflux and analyzed by flow cytometry. Histograms depict the cellular fluorescence intensity of the negative control pTM1 empty vector (gray shaded peak), ABCG2 (black thick line), ABCG2-ABCG2 (gray thick line), ABCG2 (D210N) (black thin line), and ABCG2 (D210N)-ABCG2 (dashed line). Login to comment
195 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:195:64
status: VERIFIED
view ABCG2 p.Arg482Thr details
In six-well plates, MCF-7/ AdVp3000 cells overexpressing ABCG2 (R482T) were incubated with a 1 mM solution of DPDPB for 2 h at 4 °C. Login to comment
201 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:201:12
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:201:126
status: VERIFIED
view ABCG2 p.Arg482Thr details
When ABCG2 (R482T) was cross-linked with DPDPB, a higher molecular mass species at a molecular mass consistent with an ABCG2 (R482T) dimer (Figure 4, lane 2) was apparent, as compared to the monomer species observed in the absence of the cross-linker (Figure 4, lane 1). Login to comment
211 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:211:346
status: VERIFIED
view ABCG2 p.Arg482Thr details
To determine if the extracellular cysteine residues are crucial for activity, the ABCG2∆EC-C variant was expressed in HeLa cells, and drug transport activity was measured as described in Experimental Procedures. We observed that the ABCG2∆EC-C variant had comparable levels of transport FIGURE 3: Nucleotide cross-linking of ABCG2 (R482T) in cell membranes. Login to comment
214 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 16086592:214:282
status: VERIFIED
view ABCG2 p.Arg482Thr details
Proteins (5 µg in panel B and 25 µg in panel C) were separated by SDS-PAGE (7.5% gel) and detected by immunoblot analysis using the monoclonal antibody BXP-21 (1:1000) as described in Experimental Procedures. FIGURE 4: Sulfhydryl-reactive chemical cross-linking of ABCG2 (R482T) in whole cells. Login to comment
219 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:219:191
status: VERIFIED
view ABCG2 p.Arg482Gly details
Crude HeLa cell membrane preparations of cells transiently overexpressing the ABCG2 and ABCG2∆EC-C were incubated in the presence (stimulated) and absence (basal) of 20 µM ABCG2 (R482G) substrate prazosin. Login to comment
220 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:220:116
status: VERIFIED
view ABCG2 p.Arg482Gly details
The ABCG2∆EC-C variant demonstrated drug-stimulated ATPase activity comparable to the parent protein, ABCG2 (R482G), with perhaps a slight increase in the basal activity (Figure 5D). Login to comment
235 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:235:158
status: VERIFIED
view ABCG2 p.Arg482Gly details
Basal (gray bars) and drug-stimulated ATPase activity (black bars) of pTM1 (negative control empty vector), ABCG2 (R482), and ABCG2∆EC-C in the ABCG2 (R482G) background. Login to comment
242 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 16086592:242:267
status: VERIFIED
view ABCG2 p.Lys86Met details
These data are corroborated by two studies that demonstrated co-immunoprecipitation of differentially tagged ABCG2 monomers (5, 26), including dominant-negative effects upon coexpression of wild-type ABCG2 and inactive ABCG2 molecules containing a Walker A mutation (K86M) (26) or a Leu to Pro mutation in the fifth transmembrane segment at position 554 (5). Login to comment
243 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 16086592:243:13
status: VERIFIED
view ABCG2 p.Lys86Met details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:243:117
status: VERIFIED
view ABCG2 p.Asp210Asn details
However, the K86M mutation appears to have a more dramatic effect on targeting of ABCG2 to the cell surface than the D210N mutation described here. Login to comment
244 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 16086592:244:120
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 16086592:244:154
status: VERIFIED
view ABCG2 p.Lys86Met details
ABCG2 p.Asp210Asn
X
ABCG2 p.Asp210Asn 16086592:244:65
status: VERIFIED
view ABCG2 p.Asp210Asn details
By cell surface biotinylation experiments, we showed that ABCG2 (D210N) is expressed at the surface similarly to ABCG2 (R482G) (Figure 2B) whereas ABCG2 (K86M) is found predominantly in the endoplasmic reticulum with a small percentage localized to the plasma membrane (26). Login to comment